Pre-B cell leukemia associated with chromosome translocation 1;19

Area of Science:

• Cytogenetics
• Pediatric Oncology
• Hematology

Background:

• Acute lymphocytic leukemia (ALL) is a heterogeneous group of lymphoid malignancies.
• Subclassification of ALL based on immunophenotype is crucial for prognosis and treatment.
• Chromosomal abnormalities are common in ALL and often correlate with clinical outcomes.

Purpose of the Study:

• To investigate chromosomal aberrations in a cohort of pediatric ALL patients.
• To identify novel chromosomal translocations associated with specific ALL immunophenotypes.
• To evaluate the prognostic significance of any newly identified translocations in ALL.

Main Methods:

• Chromosome banding analysis (karyotyping) was performed on bone marrow samples from 60 children diagnosed with ALL.
• Patients were classified based on immunophenotype: "null" cell, pre-B cell, B cell, and T cell ALL.
• Statistical analysis was used to correlate chromosomal findings with immunophenotype and treatment outcomes.

Main Results:

• A novel chromosome translocation, t(1;19)(q23;q13), was identified in 4 out of 17 patients with pre-B cell ALL.
• This specific translocation was absent in patients with "null" cell, B cell, or T cell ALL.
• All patients harboring the t(1;19)(q23;q13) translocation experienced early treatment failure.

Conclusions:

• The t(1;19)(q23;q13) translocation represents a distinct cytogenetic abnormality associated with pre-B cell ALL.
• This translocation may serve as a marker for a subgroup of pre-B ALL patients with a particularly poor prognosis.
• Further research is warranted to elucidate the biological mechanisms underlying the poor outcome associated with t(1;19)(q23;q13).